About Rho GTPase-activating protein 36
Rho GTPase-activating protein 36 (ARHGAP36) is a protein
from Homo sapiens identified by UniProt accession
Q6ZRI8, 547 residues long.
MolForge cross-references it against 0 known binders and
38 disease associations.
Target properties
| Protein name | Rho GTPase-activating protein 36 |
| UniProt accession | Q6ZRI8 |
| Gene | ARHGAP36 |
| Organism | Homo sapiens |
| Length | 547 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (38)
Diseases linked to this target (Open Targets).
- Bazex-Dupre-Christol syndrome · score 0.19
- Bazex-Dupré-Christol syndrome · score 0.19
- pituitary cancer · score 0.05
- platelet count · score 0.02
- age at menarche · score 0.02
- breast carcinoma · score 0.02
- age at voice drop · score 0.02
- sarcopenia · score 0.02
- papillary thyroid carcinoma · score 0.01
- acute quadriplegic myopathy · score 0.01
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q6ZRI8-F1 | alphafold | PREDICTED | 68.00 | — |
Amino-acid sequence (547 residues)
MGGCIPFLKA ARALCPRIMP PLLLLSAFIF LVSVLGGAPG HNPDRRTKMV SIHSLSELER LKLQETAYHE LVARHFLSEF KPDRALPIDR PNTLDKWFLI LRGQQRAVSH KTFGISLEEV LVNEFTRRKH LELTATMQVE EATGQAAGRR RGNVVRRVFG RIRRFFSRRR NEPTLPREFT RRGRRGAVSV DSLAELEDGA LLLQTLQLSK ISFPIGQRLL GSKRKMSLNP IAKQIPQVVE ACCQFIEKHG LSAVGIFTLE YSVQRVRQLR EEFDQGLDVV LDDNQNVHDV AALLKEFFRD MKDSLLPDDL YMSFLLTATL KPQDQLSALQ LLVYLMPPCH SDTLERLLKA LHKITENCED SIGIDGQLVP GNRMTSTNLA LVFGSALLKK GKFGKRESRK TKLGIDHYVA SVNVVRAMID NWDVLFQVPP HIQRQVAKRV WKSSPEALDF IRRRNLRKIQ SARIKMEEDA LLSDPVETSA EARAAVLAQS KPSDEGSSEE PAVPSGTARS HDDEEGAGNP PIPEQDRPLL RVPREKEAKT GVSYFFP
Explore Rho GTPase-activating protein 36 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets